
Congress trades
SpringWorks Therapeutics, Inc. (SWTX)
NASDAQ · Healthcare · 6 congress trades · last filed 1 year agono longer trading under this ticker
About SpringWorks Therapeutics, Inc.
from the company's filings and listing, as of Oct 24, 2026- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Biotechnology
- Chief executive
- -
- Employees
- 368
- Listed since
- -
- Market value
- $3.5Blast quoted Jul 1, 2025
- Price to earnings (12 mo)
- -
- Net income per share, as reported (12 mo)
- -
- Dividend yield
- -
Earnings
6 reported quarters| Quarter | EPS | EPS expected | Revenue | Revenue expected | Result |
|---|---|---|---|---|---|
| Aug 6, 2025 | -$0.54 | -$0.81 | n/a | $73.4M | EPS beatRevenue n/a |
| Q1 FY2025reported May 9, 2025 | -$1.11 | -$0.81 | $49.1M | $67.0M | EPS missRevenue miss |
| Q4 FY2024reported Feb 20, 2025 | -$1.04 | -$0.72 | $61.5M | $66.7M | EPS missRevenue miss |
| Q3 FY2024reported Nov 12, 2024 | -$0.72 | -$0.76 | $49.3M | $57.1M | EPS beatRevenue miss |
| Q2 FY2024reported Aug 7, 2024 | -$0.54 | -$1.12 | $59.7M | $34.3M | EPS beatRevenue beat |
| Q1 FY2024reported May 2, 2024 | -$1.18 | -$1.17 | $21.0M | $12.2M | EPS in lineRevenue beat |
Actual against the consensus estimate at the time. A flag marks a beat or a miss of more than 1.5% either way; inside that band the quarter is in line. A flag reads n/a only when a number is missing. An estimate is a forecast made by analysts, not a company target.
Executive pay
as filed for fiscal 2024 · proxy filed Apr 4, 2025| Executive | Salary | Stock awards | Other | Total |
|---|---|---|---|---|
| Saqib Islam, J.D.Chief Executive Officer | $760K | $7.9M | $7.5M | $16.2M |
| Badreddin Edris, Ph.D.Chief Operating Officer | $620K | $1.6M | $3.7M | $5.9M |
| James Cassidy, M.D., Ph.D.Chief Medical Officer | $525K | $1.1M | $2.5M | $4.1M |
| Bhavesh Ashar, M.B.A.Chief Commercial Officer | $525K | $1.0M | $2.3M | $3.9M |
| Francis I. PerierJr., M.B.A., Chief Financial Officer | $510K | $812K | $1.9M | $3.2M |
The summary compensation table from the proxy statement for fiscal 2024, with titles as filed then. Executives who have since left are not shown. Read the filing
Congress trades in SWTX
6 disclosures of 6 on record · median 24d of the 45 allowedSince the trade: the stock's move from its estimated entry price (a purchase) or estimated exit price (a sale) to its current price, the latest close we hold. Not the member's result.
| Member | Type | Action | Amount disclosed | Since the trade | Trade date | Disclosed | Delay |
|---|---|---|---|---|---|---|---|
| Josh GottheimerJoint | Stock | Sale | $1,001 - $15,000 | n/aPrice history ends Jul 1, 2025 | Jul 2, 2025 | Aug 11, 2025 | 40d |
| Gilbert Ray Cisneros, Jr. | Stock | Sale | $15,001 - $50,000 | n/aPrice history ends Jul 1, 2025 | Jul 1, 2025 | Jul 10, 2025 | 9d |
| Gilbert Ray Cisneros, Jr. | Stock | Purchase | $1,001 - $15,000 | n/aPrice history ends Jul 1, 2025 | Jan 29, 2025 | Feb 11, 2025 | 13d |
| Josh GottheimerJoint | Stock | Purchase | $1,001 - $15,000 | n/aPrice history ends Jul 1, 2025 | Jul 19, 2024 | Aug 15, 2024 | 27d |
| Josh GottheimerJoint | Stock | Sale | $1,001 - $15,000 | n/aPrice history ends Jul 1, 2025 | Jun 18, 2024 | Jul 9, 2024 | 21d |
| Josh GottheimerJoint | Stock | Purchase | $1,001 - $15,000 | n/aPrice history ends Jul 1, 2025 | May 9, 2024 | Jun 8, 2024 | 30d |
We hold no closing prices for any row shown here, so no move is shown. Not investment advice.
Estimated prices are the stock's closing price on the trade date. A disclosure gives a value band, not the price paid. Not investment advice. After a sale a positive figure means the stock kept rising after it. On an option line the prices are the stock's, never the option's: the premium is never disclosed.
A delay above 45 days is the gap between the dates on the report; we mark a filing late only after checking it.
"Not captured" means the band or the transaction type on the original report is missing from our data.
"Dates conflict" marks a row whose disclosure is dated before its trade on the record we hold. Both dates are printed as filed, and no prices or move are shown for that row.
Every Congress trade in SWTX, filterable by party, chamber, type and account.
Questions
Which members of Congress have traded SWTX?
Josh Gottheimer and Gilbert Ray Cisneros, Jr. disclosed SWTX transactions in the filings shown here.
How quickly are SWTX trades disclosed?
Congressional disclosures took a median of 24 days, against the 45 the STOCK Act allows.
How to read a STOCK Act filing
WHAT THE FILING ACTUALLY SAYS
Congress rows disclose a value range rather than an exact amount, and the STOCK Act allows up to 45 days to report. Full sourcing and the limits of this data are on the methodology page. A filing is a record of a transaction, not a signal, and nothing here is investment advice.
Data as of Oct 27, 2026.
